Kopin (KOPN) Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Kopin in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" KOPN shares.
View KOPN analyst ratings or view top-rated stocks.

2 brokers have issued 12 month price targets for Kopin's stock. Their KOPN share price forecasts range from $3.00 to $3.00. On average, they predict the company's share price to reach $3.00 in the next year. This suggests a possible upside of 38.8% from the stock's current price.
View analysts price targets for KOPN or view top-rated stocks among Wall Street analysts.

Kopin's stock was trading at $1.24 at the beginning of 2023. Since then, KOPN stock has increased by 74.3% and is now trading at $2.1615.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 1st 2023.
View our KOPN earnings forecast.

Kopin Co. (NASDAQ:KOPN) announced its quarterly earnings results on Thursday, May, 11th. The company reported ($0.03) EPS for the quarter, beating analysts' consensus estimates of ($0.04) by $0.01. The company had revenue of $10.76 million for the quarter, compared to analyst estimates of $9.50 million. Kopin had a negative net margin of 39.26% and a negative trailing twelve-month return on equity of 57.17%. During the same quarter last year, the business posted ($0.02) earnings per share.

5 employees have rated Kopin Chief Executive Officer John C. C. Fan on Glassdoor.com. John C. C. Fan has an approval rating of 100% among the company's employees. This puts John C. C. Fan in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Kopin investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Vuzix (VUZI), Micron Technology (MU), Nokia Oyj (NOK), Co-Diagnostics (CODX), OPKO Health (OPK), T2 Biosystems (TTOO), VBI Vaccines (VBIV) and AT&T (T).

Kopin trades on the NASDAQ under the ticker symbol "KOPN."

Kopin's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (1.11%), Essex Investment Management Co. LLC (0.91%), Geode Capital Management LLC (0.78%), Two Sigma Advisers LP (0.51%), Cowen Prime Advisors LLC (0.50%) and State Street Corp (0.27%). Insiders that own company stock include Bor Yeu Tsaur, David Brook, Hong K Choi, James K Brewington, Morton Collins, Paul Christopher Baker and Richard Sneider.
View institutional ownership trends.

Shares of KOPN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of KOPN stock can currently be purchased for approximately $2.16.

Kopin (NASDAQ:KOPN) has a market capitalization of $240.86 million and generates $47.40 million in revenue each year. The company earns $-19,330,000.00 in net income (profit) each year or ($0.21) on an earnings per share basis.

The company employs 181 workers across the globe.

Kopin's mailing address is 125 NORTH DRIVE, WESTBOROUGH MA, 01581. The official website for the company is www.kopin.com. The company can be reached via phone at (508) 870-5959, via email at investorrelations@kopin.com, or via fax at 508-870-0660.